Metraipolis › archive › dc_a5ba0671eebe
Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer — Europe PMC PMID:42358841
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42358841
- DOI
- 10.32604/or.2026.067443
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T09:27:53.071Z
- SHA-256 of the archived text
c452ef1b0c165b720c64b2fe3107400cd248b09a531b1dd1d9f1793ba3773b7f- Stable URL of this page
https://metraipolis.com/documento/dc_a5ba0671eebe
How to cite
Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer — Europe PMC PMID:42358841 — Europe PMC (en), https://europepmc.org/article/MED/42358841 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5ba0671eebe (Metraipolis archive dc_a5ba0671eebe, sha256 c452ef1b0c165b720c64b2fe3107400cd248b09a531b1dd1d9f1793ba3773b7f)
BibTeX
@misc{dca5ba0671eebe,
title = {Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer — Europe PMC PMID:42358841},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42358841},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5ba0671eebe; sha256 c452ef1b0c165b720c64b2fe3107400cd248b09a531b1dd1d9f1793ba3773b7f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358841. Agents can read the archived copy with the MCP tool read_document.